Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-03-06
1999-10-26
Allen, Marianne P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 530350, 530351, 530395, C07K 1452, A61K 3818, A61K 3819, C12N 1512
Patent
active
059728868
ABSTRACT:
A novel megakaryocyte differentiation factor, for example, consisting essentially of SEQ ID NO: 30; DNA coding for the megakaryocyte differentiation factor, an expression vector comprising the DNA, a host transformed with the expression vector, and a process for production of the megakaryocyte differentiation factor using the host.
The megakaryocyte differentiation factor accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelete.
REFERENCES:
Chemical Abstracts 113: 22039y, vol. 113, 1990.
H. Mizoguchi: Tanpakushitsu Kakusan Koso, 36, 1195-1201, 1991.
T. Matsuda et al.: Tanpakushitsu Kakusan Koso, 36, 1184-1194, 1991.
N. Yamaguchi et al.: "Characterization of New Human Pancreatic Cancer Cell Lines Which Propagate in a Protein-free Chemically Defined Medium," Cancer Res., 50, 7008-7014, 1990.
Ishida Nobuhiro
Iwasa Fuyuki
Kurihara Tatsuya
Miura Kenju
Nakazato Hiroshi
Allen Marianne P.
Suntory Limited
LandOfFree
Megakaryocyte differentiation factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Megakaryocyte differentiation factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Megakaryocyte differentiation factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764461